184 related articles for article (PubMed ID: 36776312)
1. Intraoperative oxygen tension and redox homeostasis in Pseudomyxoma peritonei: A short case series.
Valenzuela-Molina F; Bura FI; Vázquez-Borrego MC; Granados-Rodríguez M; Rufián-Andujar B; Rufián-Peña S; Casado-Adam Á; Sánchez-Hidalgo JM; Rodríguez-Ortiz L; Ortega-Salas R; Martínez-López A; Michán C; Alhama J; Arjona-Sánchez Á; Romero-Ruiz A
Front Oncol; 2023; 13():1076500. PubMed ID: 36776312
[TBL] [Abstract][Full Text] [Related]
2. Targeting hypoxia-mediated mucin 2 production as a therapeutic strategy for mucinous tumors.
Dilly AK; Lee YJ; Zeh HJ; Guo ZS; Bartlett DL; Choudry HA
Transl Res; 2016 Mar; 169():19-30.e1. PubMed ID: 26589109
[TBL] [Abstract][Full Text] [Related]
3. Breaking the Mucin Barrier: A New Affinity Chromatography-Mass Spectrometry Approach to Unveil Potential Cell Markers and Pathways Altered in Pseudomyxoma Peritonei.
Romero-Ruiz A; Granados-Rodríguez M; Bura FI; Valenzuela-Molina F; Rufián-Andújar B; Martínez-López A; Rodríguez-Ortiz L; Ortega-Salas R; Torres-Martínez M; Moreno-Serrano A; Castaño J; Michán C; Alhama J; Vázquez-Borrego MC; Arjona-Sánchez Á
Biol Proced Online; 2024 May; 26(1):13. PubMed ID: 38750435
[TBL] [Abstract][Full Text] [Related]
4. Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Arising from Urachus.
Liu Y; Ishibashi H; Hirano M; Takeshita K; Mizumoto A; Ichinose M; Nishino E; Kashu I; Yamamoto Y; Sugarbaker PH; Yonemura Y
Ann Surg Oncol; 2015 Aug; 22(8):2799-805. PubMed ID: 25572681
[TBL] [Abstract][Full Text] [Related]
5. Strategies for Preventing Pseudomyxoma Peritonei After Resection of a Mucinous Neoplasm of the Appendix.
Honoré C; Caruso F; Dartigues P; Benhaim L; Chirica M; Goéré D; Elias D
Anticancer Res; 2015 Sep; 35(9):4943-7. PubMed ID: 26254392
[TBL] [Abstract][Full Text] [Related]
6. Pre- and post-operative antibiotics in conjunction with cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC) should be considered for pseudomyxoma peritonei (PMP) treatment.
Merrell DS; McAvoy TJ; King MC; Sittig M; Millar EV; Nieroda C; Metcalf JL; Blum FC; Testerman TL; Sardi A
Eur J Surg Oncol; 2019 Sep; 45(9):1723-1726. PubMed ID: 30770164
[TBL] [Abstract][Full Text] [Related]
7. Impact of a modified peritoneal cancer index using FDG-PET/CT (PET-PCI) in predicting tumor grade and progression-free survival in patients with pseudomyxoma peritonei.
Hotta M; Minamimoto R; Gohda Y; Igari T; Yano H
Eur Radiol; 2019 Oct; 29(10):5709-5716. PubMed ID: 30874878
[TBL] [Abstract][Full Text] [Related]
8. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
[TBL] [Abstract][Full Text] [Related]
9. Validation of the Recent PSOGI Pathological Classification of Pseudomyxoma Peritonei in a Single-Center Series of 265 Patients Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Baratti D; Kusamura S; Milione M; Bruno F; Guaglio M; Deraco M
Ann Surg Oncol; 2018 Feb; 25(2):404-413. PubMed ID: 29159742
[TBL] [Abstract][Full Text] [Related]
10. Novel Perspectives in Pseudomyxoma Peritonei Treatment.
Sommariva A; Tonello M; Rigotto G; Lazzari N; Pilati P; Calabrò ML
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885075
[TBL] [Abstract][Full Text] [Related]
11. Rare occurrence of pseudomyxoma peritonei (PMP) syndrome arising from a malignant transformed ovarian primary mature cystic teratoma treated by cytoreductive surgery and HIPEC: a case report.
Ponzini F; Kowal L; Ghafoor M; Goldberg A; Chan J; Lamm R; Cannaday SM; Richard SD; Nevler A; Lavu H; Bowne WB; Rosenblum NG
World J Surg Oncol; 2022 Mar; 20(1):78. PubMed ID: 35272690
[TBL] [Abstract][Full Text] [Related]
12. Complete pathological response of high grade appendicular neoplasm induced Pseudomyxoma Peritonei (PMP) after neoadjuvant intra-peritoneal chemotherapy: A case report.
Padmanabhan N; Ishibashi H; Nishihara K; Sako S; Katayama K; Wakama S; Kamada Y; Yonemura Y
Int J Surg Case Rep; 2020; 72():117-121. PubMed ID: 32534414
[TBL] [Abstract][Full Text] [Related]
13. History of pseudomyxoma peritonei from its origin to the first decades of the twenty-first century.
Morera-Ocon FJ; Navarro-Campoy C
World J Gastrointest Surg; 2019 Sep; 11(9):358-364. PubMed ID: 31572561
[TBL] [Abstract][Full Text] [Related]
14. [Pseudomyxoma peritonei (PMP) secondary to mucinous carcinoma of the ovary: a case study].
Belhamidi MS; Zorkani Y; Krimou H; Kaoukabi A; Menfaa M; Sakit F; Choho K
Pan Afr Med J; 2019; 33():283. PubMed ID: 31692896
[TBL] [Abstract][Full Text] [Related]
15. A New Etiology for the Abdominal Compartment Syndrome: Pseudomyxoma Peritonei.
Sabbagh C; Vaillandet C; Tuech JJ; Regimbeau JM
Case Rep Gastroenterol; 2015; 9(3):307-10. PubMed ID: 26483617
[TBL] [Abstract][Full Text] [Related]
16. Impact of Cellularity on Oncologic Outcomes Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Pseudomyxoma Peritonei.
Choudry HA; Pai RK; Shuai Y; Ramalingam L; Jones HL; Pingpank JF; Ahrendt SS; Holtzman MP; Zureikat AH; Zeh HJ; Bartlett DL
Ann Surg Oncol; 2018 Jan; 25(1):76-82. PubMed ID: 29110275
[TBL] [Abstract][Full Text] [Related]
17. Physical and chemical characteristics of mucin secreted by pseudomyxoma peritonei (PMP).
Pillai K; Akhter J; Mekkawy A; Chua TC; Morris DL
Int J Med Sci; 2017; 14(1):18-28. PubMed ID: 28138305
[No Abstract] [Full Text] [Related]
18. Pseudomyxoma peritonei (PMP) and its therapy - 20 years experience of a single surgical department.
Bartoška P; Antoš F; Vítek P; Marx J; Holečková P; Novotný M; Kengbaeva M
Rozhl Chir; 2020; 99(4):159-166. PubMed ID: 32545978
[TBL] [Abstract][Full Text] [Related]
19. Perioperative safety after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal origin: Experience on 254 patients from a single center.
Li XB; Ma R; Ji ZH; Lin YL; Zhang J; Yang ZR; Chen LF; Yan FC; Li Y
Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):600-606. PubMed ID: 31973925
[TBL] [Abstract][Full Text] [Related]
20. Patient-derived xenograft mouse models of pseudomyxoma peritonei recapitulate the human inflammatory tumor microenvironment.
Kuracha MR; Thomas P; Loggie BW; Govindarajan V
Cancer Med; 2016 Apr; 5(4):711-9. PubMed ID: 26833741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
